New fatty liver drug shows promise in Tulane study | Health care/Hospitals
Fatty liver disease affects more than a third of adults in the United States, a silent epidemic closely tied to...
Fatty liver disease affects more than a third of adults in the United States, a silent epidemic closely tied to...
The study explored the views of healthcare providers in three health facilities regarding the barriers to accessing haemodialysis in northern...
image: Interleukin 33 (brown) upregulation in hepatitis B virus-positive chronic hepatitis. view more Credit: Shawn Demehri, Mass General Brigham Hepatitis B...
Choosing between traditional Medicare and any number of Medicare Advantage (MA) plans can be difficult, especially with the advertising onslaught...
People who have early signs of heart problems may also have changes in brain health that can be early signs...
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...